Progression & Subtype Evolution
Track how patients move between SM subtypes and surface early progression signals from claims.
Progressing share
20%
Progressed share
11%
Documented progression events
219
Subtype migration
Initial subtype → current subtype (incl. SSM, MCL)
Cohort composition over time
Progression signals
Patients with claims-derived risk indicators
| Patient | Subtype | Signal | Risk |
|---|---|---|---|
| P100006 | ISM-low | Tryptase trend ↑, ED visits +2 | Moderate |
| P100009 | AdvSM | Organ involvement codes + tryptase ↑ | High |
| P100011 | ISM-low | Tryptase trend ↑, ED visits +2 | Moderate |
| P100014 | ISM-high | Tryptase trend ↑, ED visits +2 | Moderate |
| P100015 | AdvSM | Organ involvement codes + tryptase ↑ | High |
| P100016 | ISM-high | Tryptase trend ↑, ED visits +2 | Moderate |
| P100017 | ISM-high | Tryptase trend ↑, ED visits +2 | Moderate |
| P100018 | ISM-low | Tryptase trend ↑, ED visits +2 | Moderate |
| P100026 | ISM-low | Organ involvement codes + tryptase ↑ | High |
| P100027 | AdvSM | Organ involvement codes + tryptase ↑ | High |
| P100029 | ISM-high | Organ involvement codes + tryptase ↑ | High |
| P100034 | AdvSM | Organ involvement codes + tryptase ↑ | High |